Literature DB >> 18849896

The contemporary face of bipolar illness: complex diagnostic and therapeutic challenges.

Konstantinos N Fountoulakis1.   

Abstract

Manic depression, or bipolar disorder, is a multifaceted illness with an inevitably complex treatment. The current article summarizes the current status of our knowledge and practice concerning its diagnosis and treatment. While the prototypic clinical picture concerns the "classic" bipolar disorder, today mixed episodes with incomplete recovery and significant psychosocial impairment are more frequent. The clinical picture of these mixed episodes is variable, eludes contemporary classification systems, and possibly includes a constellation of mental syndromes currently classified elsewhere. Treatment includes the careful combination of lithium, antiepileptics, atypical antipsychotics, and antidepressants, but not all of the agents in these broad categories are effective for the treatment of bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849896     DOI: 10.1017/s1092852900013894

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  8 in total

Review 1.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

2.  Item response modeling of DSM-IV mania symptoms in two representative US epidemiological samples.

Authors:  A Agrawal; J I Nurnberger; M T Lynskey
Journal:  Psychol Med       Date:  2009-12-02       Impact factor: 7.723

3.  Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review.

Authors:  Konstantinos N Fountoulakis; Eduard Vieta
Journal:  Ann Gen Psychiatry       Date:  2009-07-27       Impact factor: 3.455

4.  Borderline personality disorder: bipolarity, mood stabilizers and atypical antipsychotics in treatment.

Authors:  Hasan Belli; Cenk Ural; Mahir Akbudak
Journal:  J Clin Med Res       Date:  2012-09-12

5.  3'-5' phosphoadenosine phosphate is an inhibitor of PARP-1 and a potential mediator of the lithium-dependent inhibition of PARP-1 in vivo.

Authors:  Elie Toledano; Vasily Ogryzko; Antoine Danchin; Daniel Ladant; Undine Mechold
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

Review 6.  The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines.

Authors:  Konstantinos N Fountoulakis; Allan Young; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Pierre Blier; Hans Jurgen Moeller; Siegfried Kasper
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

7.  Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis.

Authors:  Konstantinos N Fountoulakis; Xenia Gonda; Eduard Vieta; Frank Schmidt
Journal:  Ann Gen Psychiatry       Date:  2009-12-31       Impact factor: 3.455

8.  Effectiveness of cognitive analytic therapy for bipolar affective disorder: A co-produced single subject cumulative treatment design with extended follow-up (A1 /B/A2 /C-FU).

Authors:  Stephen Kellett; Lisa Alhadeff; Chris Gaskell; Melanie Simmonds-Buckley
Journal:  Psychol Psychother       Date:  2022-03-10       Impact factor: 3.966

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.